Key Takeaways

• STI rates in Australia are rising, with chlamydia and gonorrhoea being among the most common. Women face higher risks of long-term health complications if left undiagnosed.
• Early detection is crucial—both infections can be asymptomatic, making regular testing essential for preventing serious reproductive health issues and reducing transmission.
• Touch Biotechnology introduces Australia's first and only ARTG-listed self-test kit for chlamydia and gonorrhoea, offering a private, fast, and convenient testing option.
• Self-testing empowers individuals by removing barriers such as stigma, inconvenience, and lack of access to clinics. Results are available in just 15 minutes.
  
• TouchBio is leading the way in healthcare innovation, continuously developing solutions that support early detection and better public health outcomes.
  

Why Regular STI Testing Matters for Women in Australia

Sexually transmitted infections (STIs) are a growing concern in Australia, with chlamydia and gonorrhoea being among the most common. These infections often show no symptoms, leading many individuals to unknowingly carry and spread them.

For women, untreated STIs can lead to severe health complications, including pelvic inflammatory disease, infertility, and increased susceptibility to other infections. Early detection is key—not just for personal health, but also to prevent the spread of these infections within the community.

Consider this: A recent study found that 80% of women with chlamydia show no symptoms, meaning they may go months or even years without realizing they are infected. By the time they do, complications may already have set in. Regular testing ensures timely treatment, reducing risks and protecting future reproductive health.

TouchBio: Leading Innovation in STI Self-Testing

At Touch Biotechnology, we recognize the urgent need for accessible STI testing. That’s why we developed Australia’s first and only rapid self-test for chlamydia and gonorrhoea.

• ARTG Listed – Meets high regulatory standards for safety and reliability.
  
• 15-Minute Results – No waiting in lines or appointment
  
• Private & Convenient First Screening – Test in the privacy of your home.
  
• Highly Accurate – Reliable results to ensure status of your health.

This breakthrough offers a game-changing solution, particularly for those who may have barriers to traditional testing brought by stigma and inconvenience.

Supporting Pharmacies, Hospitals & Health Organizations

TouchBio is committed to making STI testing more accessible by partnering with pharmacies, hospital groups, and health organizations. Together, we can ensure individuals have a fast, private, and reliable way to monitor their sexual health.

Pharmacies stocking the TouchBio STI Self-Test Kit can play a crucial role in removing stigma, improving detection rates, and ultimately reducing STI transmission in the community. 

Healthcare organizations can integrate self-testing into their public health initiatives, ensuring more individuals get tested regularly.

Join Us in Changing the Future of STI Testing

By making self-test kits widely available, we are taking a step toward reducing STI rates and empowering individuals with knowledge about their health.

TouchBio is actively seeking partners to distribute, stock, and promote self-testing solutions as part of a larger movement for sexual health awareness and early detection.

📩 Get in Touch!

Let’s work together to bring this groundbreaking solution to those who need it most.

For partnership inquiries, orders, or more information, contact us at touch@touchaustralia.com.au or visit www.touchaustralia.com.au.

Together, we can innovate for a healthier future.

References:

1. News-Medical. (n.d.). Chlamydia symptoms. News-Medical.net. Retrieved from https://www.news-medical.net/health/Chlamydia-Symptoms.aspx